Works matching IS 13665278 AND DT 2023 AND VI 27 AND IP 23/24


Results: 2
    1
    2

    A pragmatic, multicentre, double-blind, placebocontrolled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

    Published in:
    Health Technology Assessment, 2023, v. 27, n. 23/24, p. vii, doi. 10.3310/VPDT7105
    By:
    • Banerjee, Sube;
    • Farina, Nicolas;
    • Henderson, Catherine;
    • High, Juliet;
    • Stirling, Susan;
    • Shepstone, Lee;
    • Fountain, Julia;
    • Ballard, Clive;
    • Bentham, Peter;
    • Burns, Alistair;
    • Fox, Chris;
    • Francis, Paul;
    • Howard, Robert;
    • Knapp, Martin;
    • Leroi, Iracema;
    • Livingston, Gill;
    • Nilforooshan, Ramin;
    • Nurock, Shirley;
    • O'Brien, John;
    • Price, Annabel
    Publication type:
    Article